Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03830320 · ClinicalTrials.gov registry record · Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
A Phase 1 study of Cancer and COVID-19, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 165
- Enrollment target
- 1
- Study location
NCT03830320: Recruiting Phase 1 study of Cancer and COVID-19, sponsored by Massachusetts General Hospital.
NCT03830320 is a Phase 1 study of Cancer and COVID-19 that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 165 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03830320, a Phase 1 study of Cancer and COVID-19, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 165 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to evaluate a new radiotracer called 64Cu-FBP8 for PET-MR imaging of thrombosis. The tracer has the potential of detecting thrombosis anywhere in the body, for instance in the left atrial appendage of patients with atrial fibrillation, and thereby may provide a non-invasive alternative to the current standard-of-care methods.
Primary Outcome
To model pharmacokinetics of \[64Cu\]FBP8 metabolism in healthy volunteers.
Conditions Studied
Interventions
- PROCEDURE Electrocardiogram
- DRUG [64Cu]FBP8
- DEVICE PET/MR
- PROCEDURE Blood Collection
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2016-04-01 |
| Est. Completion | 2027-01-31 |
| Phase | Phase 1 |
What NCT03830320 shows while recruiting
NCT03830320 is an interventional study that assigns participants to a tested intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower).
The record links to 4 conditions, with Cancer appearing as the primary indexed condition, and to 4 interventions - of which Electrocardiogram is the first listed.
NCT03830320 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03830320 about?
NCT03830320 is a clinical study titled "Positron Emission Tomography (PET) Imaging of Thrombosis". The purpose of the study is to evaluate a new radiotracer called 64Cu-FBP8 for PET-MR imaging of thrombosis. The tracer has the potential of detecting thrombosis anywhere in the body, for instance in the left atrial appendage of patients with atrial fibrillation, and thereby may provide a non-invasi...
What is the current status of trial NCT03830320?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 165 participants. The study started on 2016-04-01. Estimated completion is 2027-01-31.
What conditions does trial NCT03830320 study?
This clinical trial studies the following conditions: Cancer, COVID-19, Atrial Fibrillation, Thrombosis.
What interventions are being tested in trial NCT03830320?
The interventions under investigation include: Electrocardiogram (PROCEDURE), [64Cu]FBP8 (DRUG), PET/MR (DEVICE), Blood Collection (PROCEDURE).
Who is sponsoring clinical trial NCT03830320?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03830320 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03830320's enrollment target sits among peer trials
165 256th of 615 higher than 359 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
RECRUITING · Phase 1
-
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
Impact of Daily Oral Cannabis Doses in Patients With Cancer
RECRUITING · Phase 1
-
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02387255 · 165 participants
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
- NCT03351348 · 165 participants · Phase 3
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
- NCT04289571 · 165 participants · Phase 1
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
- NCT04458584 · 165 participants
Restoration of Thumb Strength and Function in Basal Joint Arthritis: A Comparative Effectiveness Trial (RESTART)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI